European Companies Search Engine
Capital: €65,100 · Shareholder agreement · Corporate Purpose Hrb6 Mar 2006 German Trade Register Announcements, Germany (02/03/2006)
Overview
Text
ALRISE Biosystems GmbH, Berlin (
Unnamed street ??, 10117 Berlin, Germany
). Subject: The microencapsulation of active substances, in particular biopharmaceuticals or biodiagnostics with the help of biologically compatible and targeted biopolymers as a service in development and production for pharmaceutical and diagnostic companies. Share capital: EUR 65,100; Legal form: By resolution of the shareholders' meeting of January 16, 2006, the share capital is increased by EUR 40,100 to EUR 65,100 and the СД agreement has been amended in paragraph 4 (share capital) and completely redrafted.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: ALRISE Biosystems GmbH, Berlin, Germany.
